CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NVS

LOU064 (blinded)

Phase 3
Novartis AG (NVS)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Nov '26
NVSPhase 3

LOU064 (blinded) Phase 3 Est. Readout

LOU064 (blinded)
Nov 2026~
CT.gov
00%
Competitive Landscape

1 competitor in Chronic Spontaneous Urticaria

View Full Landscape
Drug Information

Target Indication

Chronic Spontaneous Urticaria

Clinical Trial

NCT05677451

Last updated: 2/9/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.